EPRXEupraxia Pharmaceuticals Inc.
$7.47+22% 1Y
$7.47
$5.3352 weeks$9.12
EPRX in its own filings
Nothing in EPRX's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
90
Events found in the filings · across 124 filings · the record starts in 2024
- Hard flags
- none
Hard flags
- Most recent filing
- Oct 9, 2026
Most recent filing · Form 6-K
- Record starts
- Mar 11, 2024
Record starts · the earliest filing Ryufin holds for this name
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
opening the record…
Biotechnology
The closest names by size in the same industry